A Ring-type Wearable Device for Atrial Fibrillation
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jul 15, 2019
Trial Information
Current as of September 13, 2025
Unknown status
Keywords
ClinConnect Summary
1. Study title: Diagnostic Performance of a Ring-type Wearable Device Using Deep Learning Analysis of Photoplethysmographic Signals for Detecting Atrial Fibrillation.
2. Study type: Investigator initiated study.
3. Study design: Prospective observational cohort registry design.
4. Sponsor: Sky Labs, Inc., Republic of Korea.
5. The aim of the study: To evaluate diagnostic performance of a ring-type wearable device for detecting atrial fibrillation.
6. Study period: From the date of IRB approval to 31th Dec. 2019.
7. The size of study population: 200 participants
8. The eligibility criteria:
...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those with persistent atrial fibrillation
- • Those who admitted for elective direct-current cardioversion
- • Those who aged 19 years or more
- Exclusion Criteria:
- • Those who aged less than 19 years
- • Those who had other types of cardiac arrhythmias
- • Those who are not eligible to perform electrical cardioversion
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, Korea, Republic Of
Patients applied
Trial Officials
Eue-Keun Choi, MD, PhD
Principal Investigator
Devision of Cardiology, Department of Internal Medicine, Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials